Advertisement · 728 × 90

Posts by Walid Gellad

Preview
Data suggest Paxlovid doesn't reduce severe COVID in older, vaccinated adults

this study made me think of @walidgellad.bsky.social
www.cidrap.umn.edu/covid-19/dat...

1 year ago 2 1 1 1

this brings back fond memories. thanks for sharing.

1 year ago 0 0 0 0
Preview
FDA finds little handwashing, dirty equipment at McDonald's supplier linked to E. coli outbreak More than a hundred E. coli cases were linked to contaminated onions produced by Taylor Farms used in McDonald's burgers.

Remember E. coli outbreak linked to onions in McDonald's Quarter Pounders?

FDA inspectors found dozens of violations at supplier, like:

- ignoring biofilm/debris buildup
- not using handwashing sinks
- cleaning chemicals getting on food

www.cbsnews.com/news/fda-rep...

1 year ago 26 13 1 2

Truly, one of the best changes to Medicare in decades. If you need a very expensive medicine (or a lot of medicine) and you are on Medicare you now have a hard cap on spending starting on 1/1. That is awesome.

1 year ago 30 6 1 1
Post image

FDA transfers regulatory oversight of medical maggots and leaches from its device center (the organisms previously regulated as medical devices) to biologics center

public-inspection.federalregister.gov/2024-31266.p...

More on their clinical applications here

pmc.ncbi.nlm.nih.gov/articles/PMC...

1 year ago 30 13 4 7
Post image
1 year ago 3 0 0 0
Health Services, Policy & Practice | School of Public Health | Brown University Imagine a world where everyone has access to quality health care—regardless of their social status, ethnicity or financial situation.

Some news ...

I'm thrilled to announce that I'll be joining the Brown School of Public Health as a Professor of Health Services Policy & Practice this upcoming summer, 2025! I'm excited for the move and the opportunity to grow my research in new directions.

hspp.sph.brown.edu

1 year ago 116 5 20 0
Advertisement

I'm looking for a third paper for a Medicaid managed care-focused panel for ASHE. DM me if interested!

Please RT, I'm new to the blue skies...

1 year ago 24 35 3 3

CP3 Associate Director Dr. Katie Suda is learning from past #drugshortages to help mitigate future ones. take a look at her most recent paper comparing US vs Canada.

jamanetwork.com/journals/jam...

1 year ago 3 2 0 0
Preview
Same Drug, 2,200 Different Prices Middlemen negotiate widely different prices for prescriptions, depending on your Medicare insurance plan.

When prescription drug costs are subjectively set by conflicted intermediates who profit off higher prices and misaligned incentives, the sticker shock isn’t really a shock at all. www.wsj.com/health/healt... @wsj.com

1 year ago 493 98 15 7
Preview
Generalizability of Clinical Trial Findings of Novel Weight Loss Medications This cross-sectional study investigates the extent to which individuals meeting label criteria for novel weight loss medications may not have been included in pivotal trials.

🆕from @LilyBessette & CP3's @TimAndersonMD - a third of patients eligible for weight loss 💊would have been excluded from their clinical trials.

Read more @JAMAInternalMed
jamanetwork.com/journals/jam...

1 year ago 1 2 0 0
Post image Post image Post image Post image

Reprising this from my AEI colleague Ben Ippolito on the cost of Medicare coverage for GLP-1s. CMS appears to see writing on wall here: As additional indications are approved, most Medicare recipients will get coverage for other co-morbidities. Also, Semaglutide subject to IRA price controls in 2027

1 year ago 30 14 1 1
Post image Post image Post image

My article in @statnews.bsky.social on GLP-1 compounding: the @fda.gov needs to maintain the integrity of its authorities — and the implementation of the Drug Quality and Security Act (DQSA).

www.statnews.com/2024/11/19/f...

1 year ago 43 10 2 1
Preview
Bluesky is the new destination for X/Twitter’s health and science community. Here's why #MedTwitter is migrating en masse from X to Bluesky, suddenly making it an essential hub for scientific discourse. Here's why.

I do hope it sticks this time @katiepalmer.bsky.social! Nice comments from @walidgellad.bsky.social and @scottgottliebmd.bsky.social.

1 year ago 19 8 1 0

Yes all under 12 is eua and all novo vax.

1 year ago 1 0 0 0
Post image

ICYMI: Our team previously showed ⬆️prices for indomethacin suppositories. Now, we found wide variation in hospital charges for this drug - charges passed to patients b/c the suppositories are excluded from Medicare Parts B&D.

More in JAMA Network Open
jamanetwork.com/journals/jam...

1 year ago 1 1 0 0
A screenshot of tables that reads in part: "Accord Healthcare Inc. (New 02/29/2024) Company Contact Information: 866-941-7875, option 2 Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA) Tablet, 50 mg (NDC 16729-081-01)	Not Available. Resupply TBD		Shortage of an active ingredient Tablet, 50 mg (NDC 16729-081-10)	Available and shipping Customers Sales Orders		Shortage of an active ingredient Elite Laboratories, Inc. (New 02/29/2024) Company Contact Information: 800-397-9228 Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA) Tablet, 50 mg (NDC 51224-206-50)	Available	Marketed by Tagi Pharma Tablet, 50 mg (NDC 51224-206-30)	Available	Marketed by Tagi Pharma Tablet, 50 mg (NDC 68094-909-50)	Available	Marketed by Precision Dose Tablet, 50 mg (NDC 68094-909-30)	Available	Marketed by Precision Dose SpecGx LLC (New 02/29/2024) Company Contact Information: 800-325-8888 Presentation	A

A screenshot of tables that reads in part: "Accord Healthcare Inc. (New 02/29/2024) Company Contact Information: 866-941-7875, option 2 Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA) Tablet, 50 mg (NDC 16729-081-01) Not Available. Resupply TBD Shortage of an active ingredient Tablet, 50 mg (NDC 16729-081-10) Available and shipping Customers Sales Orders Shortage of an active ingredient Elite Laboratories, Inc. (New 02/29/2024) Company Contact Information: 800-397-9228 Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA) Tablet, 50 mg (NDC 51224-206-50) Available Marketed by Tagi Pharma Tablet, 50 mg (NDC 51224-206-30) Available Marketed by Tagi Pharma Tablet, 50 mg (NDC 68094-909-50) Available Marketed by Precision Dose Tablet, 50 mg (NDC 68094-909-30) Available Marketed by Precision Dose SpecGx LLC (New 02/29/2024) Company Contact Information: 800-325-8888 Presentation A

Oral naltrexone is one of main medications doctors can turn to for treating alcohol use disorder

FDA now lists it in shortage, with multiple manufacturers citing a "Shortage of an active ingredient" or "Demand increase for the drug"

www.accessdata.fda.gov/scripts/drug...

2 years ago 5 2 0 1
Advertisement

I’m not posting much here, but I’d like to point out that it is tweets like this that exaggerate study findings. Stat shouldn’t do this. This study design cannot measure impact of COVID on cognition. Rather it compares cognition in those with and without COVID/symptoms with no baseline measure.

2 years ago 4 0 0 0

Bad time to bring up that as a VA researcher one can get access to all VA data linked to Medicare and Medicaid claims data all in a virtual desktop for free?

2 years ago 2 1 1 0
Post image

Good piece. Remember our collaboration few years ago related to this topic (where is development happening)

jamanetwork.com/journals/jam...

2 years ago 2 1 0 0
Admissions Events | School of Public Health Prospective Bachelor's Students Register for an in-person or virtual information session for the Bachelor of Science in Public Health program through Pitt Undergraduate Admissions.

Prospective PhD students: Applications are now open for the
#PittHPM Health Services Research and Policy PhD program! Join #PittPubHealth for info sessions in October (virtual) and November 3 (in-person)

2 years ago 0 1 1 0
Post image

The Department of Health Policy and Management at Pitt is hiring tenure track faculty in policy and health services research. Apply. French fries on salads.

cfopitt.taleo.net/careersection/pitt_facul...

2 years ago 8 4 0 0

Re-upping this since the health policy contingent is slowly but steadily growing:

BlueSky has "feeds," which are sort of like Twitter's lists, but you typically need to use a keyword (or key emoji) to have a post feature in the feed.

I created a health policy feed here:

2 years ago 13 10 2 0

You should check this out - use the #healthpolicy hashtag to get posts to go into this feed. You can also pin the feed to your dashboard so you can just see these posts (very useufl, IMO).

2 years ago 0 1 0 0
Advertisement

Welcome, @bnrome.bsky.social ! Check out the health policy list and instructions for contributing to that feed. You can pin the feed to easily get back to it.

2 years ago 1 1 0 1
Post image

Original Humira’s list price grew so much that its actual price after rebates to Medicaid was zero.

(It will be fascinating to see what happens in Medicare with inflation rebate). #healthpolicy

jamanetwork.com/journals/jamanetworkopen...

2 years ago 4 1 0 0

ICER's report on sickle cell disease🧪 is out today!

Current evidence suggests that lovo-cel and exa-cel would achieve common thresholds for cost-effectiveness if priced between $1.35M to $2.05M

#healthpolicy

2 years ago 5 4 0 0
Preview
New Biden initiative targets controversial hospital 'facility fees' that often surprise patients A new Biden administration initiative requires hospitals to “make information about these facility fees publicly available to consumers.”

“Another hospital attempted to charge a patient a facility fee of up to $350 for a telehealth visit because the doctor was on hospital property.” 🙃

#healthpolicy

www.statnews.com/2023/07/07/hospital-faci...

2 years ago 6 4 0 0

Happy to share our new piece answering the ? "What bar should CMS consider when determining what 'bona fide generic entry' means." #healthpolicy

www.nejm.org/doi/full/10.1056/NEJMp23...

2 years ago 4 2 0 2

Testing the waters here.

this ability to follow specific feeds based on hashtags right from the app is a big plus.

Although not to ruin things but I see potential for topic specific ads in specific feeds.

2 years ago 4 0 0 0